Sort
8,912 grants matching “sars cov 2”
Improving the clarification, characterization, and homogeneity of animal serum through Nanotrap nanoparticle technology
$162,371Benjamin Scott Lepene · Ceres Nanosciences, Lllp · R43 · FY2021 · GM
RAPID: Host-pathogen interactions during genome replication of SARS-CoV2
$162,283Taekjip Ha · Johns Hopkins University · · FY2020 · BIO
Buffering effects of a tiered preventive model on parent adjustment, parent-child relational health, and child psychosocial development post COVID-19
$162,137Pamela A Morris · New York University · R01 · FY2022 · HD
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus Infection
$162,000Anthony R Fehr · University Of Kansas Lawrence · K22 · FY2019 · AI
P3: EphA2 Targeting in Uterine Carcinoma
$162,000Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
SARS-CoV-2, ACE2 and Esophageal Neoplasia
$162,000Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2020 · CA
Elucidating the Cardioprotective Role of Fetal-derived CD8+ T Cells During Viral-induced Myocarditis
$162,000Zachary T Hilt · University Of Toledo Health Sci Campus · K22 · FY2025 · AI
Evaluation of siRNA nanoformulations and aerosol delivery for treatment of SARS-CoV-2
$162,000Karen Hsieh Lu · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Columbia University Minority/Underserved Site NCI Community Oncology Research Program
$162,000Gary K Schwartz · Columbia University Health Sciences · UG1 · FY2020 · CA
UChicago Interdisciplinary Cancer Health Disparities SPORE
$162,000Olufunmilayo I Olopade · University Of Chicago · P20 · FY2020 · CA
Administrative Core
$162,000Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2020 · CA
Clinical Core
$161,973Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2024 · AI
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$161,896Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Alzheimer's Disease Research Center Determinants of health seeking behaviors during COVID-19 in persons with MCI/ADRD and their caregivers
$161,548Scott A Small · Columbia University Health Sciences · P30 · FY2020 · AG
Administrative Core
$161,548Scott A Small · Columbia University Health Sciences · P30 · FY2020 · AG
COVID-19 Pandemic among low-income Latino families in an agricultural community: Financial, occupational, and mental and physical health sequelae
$161,528Brenda Eskenazi · University Of California Berkeley · R01 · FY2020 · ES
Targeting the Inflammasome As a Treatment Strategy for COVID-19 infected cancer patients
$161,500Jenny C-N Chang · Methodist Hospital Research Institute · U54 · FY2020 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$161,500Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2020 · CA
A Precision high content screening assay for AB-mediated neuronal cell cycle reentry
$161,500Elizabeth R. Sharlow · University Of Virginia · R01 · FY2020 · AG
Development of a stable mRNA prophylactic vaccine against SARS-CoV-2 omicron variant
$161,500Junhua Mai · Methodist Hospital Research Institute · R21 · FY2025 · AI
Characterization of seasonal CoV immunity and operationalization of a novel controlled human infection model for the betacoronavirus OC43
$161,412Meagan Elise Deming · University Of Maryland Baltimore · K08 · FY2023 · AI
Clinical Core
$161,295Matthew Hamill · Johns Hopkins University · U54 · FY2025 · EB
Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery models
$160,971Kimberly A Kaphingst · University Of Utah · U01 · FY2020 · CA
Transcriptional and non-transcriptional functions of IRF3 in ALD
$160,944Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · AA
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
$160,934Michael D Gunn · Duke University · P50 · FY2020 · CA